Human immunodeficiency virus-related renal cell carcinoma: a retrospective study of 19 cases

Table 2 Pathology, treatment, and outcomes of HIV related RCC

Case	Surgery	TNM stage	Pathology	Adjuvent therapy	Follow-up duration (months)	Outcomes
1	RN	pT1a N0 M0	Clear cell Grades 1–2	NT	96	Alive
2	PN	pT1a N0 M0	Chromophobe cell NR	NT	78	Alive
3	RN	pT1a N0 M0	Clear cell NR	NT	76	Alive
4	RN	pT2a N0 M0	Clear cell Grades 1–2	NT	68	Dead
5	RN	pT2b N0 M0 (cystic renal carcinoma)	Clear cell NR	NT	65	Alive
6	PN	pT1a N0 M0	Clear cell Grade 3	NT	61	Alive
7	RN	pT1a N0 M0	Clear cell Grades 1–2	NT	47	Alive
8	RN	pT3b N0 M0 (inferior vena cava cancerous suppository)	Partially clear cell, partially papillary Grades 2–3	IFN+IL-2	35	Alive
9	RN	pT2a N0 M0	Clear cell Grades 2–3	IFN Sorafenib 4 M Sunitinib 6 M Axitinib 3 M	35	Alive (Lung and brain metastases)
10	RN	pT3a N0 M0 (perirenal adipose sac invaded)	Clear cell Grade 2	Sorafenib 3 M	35	Dead
11	RN	pT1b N0 M0	Clear cell Grade 3	NT	34	Alive
12	RN	pT1a N0 M0	Clear cell Grade 2	NT	34	Alive
13	RN	pT1b N0 M0	Clear cell NR	NT	33	Alive
14	PN	pT1a N0 M0	Clear cell Grade 2	NT	33	Alive
15	RN	pT1b N0 M0	Clear cell Grade 2	NT	32	Alive
16	RN	pT1b N0 M0	Clear cell Grade 3	NT	29	Alive
17	RN	pT1a N0 M0	Clear cell Grade 2	NT	28	Alive
18	RN	pT1b N0 M0	Clear cell Grade 3	NT	20	Alive
19	PN	pT1a N0 M0	Clear cell Grade 1	NT	14	Alive

Abbreviations: RN radical nephrectomy, PN partial nephrectomy, NR not recorded, IFN interferon, IL interleukin, NT no treatment

ISSN: 1750-9378